ID   MS428
AC   CVCL_9835
DR   EFO; EFO_0002837
DR   GEO; GSM49616
DR   Wikidata; Q54906805
RX   PubMed=15920167;
RX   PubMed=19853261;
CC   From: Fletcher, Jonathan A.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
RX   PubMed=15920167; DOI=10.1016/S0002-9440(10)62492-3; PMCID=PMC1363736;
RA   Gordon, Gavin J.
RA   Rockwell, Graham N.
RA   Jensen, Roderick V.
RA   Rheinwald, James George
RA   Glickman, Jonathan Neil
RA   Aronson, Joshua Paul
RA   Pottorf, Brian J.
RA   Nitz, Matthew David
RA   Richards, William G.
RA   Sugarbaker, David John
RA   Bueno, Raphael
RT   "Identification of novel candidate oncogenes and tumor suppressors in
RT   malignant pleural mesothelioma using large-scale transcriptional
RT   profiling.";
RL   Am. J. Pathol. 166:1827-1840(2005).
//
RX   PubMed=19853261; DOI=10.1016/j.jtcvs.2009.06.027;
RA   Hartman, Mor-Li
RA   Esposito, John Matthew
RA   Yeap, Beow Yong
RA   Sugarbaker, David John
RT   "Combined treatment with cisplatin and sirolimus to enhance cell death
RT   in human mesothelioma.";
RL   J. Thorac. Cardiovasc. Surg. 139:1233-1240(2010).
//